Woodley Farra Manion Portfolio Management’s Charles River Laboratories CRL Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$288K	Hold	1,269	–	–	0.01%	112
2026 Q1	$219K	Hold	1,269	–	–	0.01%	117
2025 Q4	$253K	Buy	+1,269	New	+$230K	0.01%	103
2025 Q3	–	Sell	-1,407	Closed	-$213K	–	120
2025 Q2	$213K	Sell	1,407 -722	-34%	-$96.3K	0.01%	111
2025 Q1	$320K	Sell	2,129 -434	-17%	-$72.8K	0.02%	90
2024 Q4	$473K	Sell	2,563 -232,588	-99%	-$44.8M	0.02%	78
2024 Q3	$46.3M	Sell	235,151 -4,620	-2%	-$960K	2.33%	22
2024 Q2	$49.5M	Sell	239,771 -3,389	-1%	-$768K	2.69%	20
2024 Q1	$65.9M	Buy	243,160 +137,120	+129%	+$32.7M	3.63%	9
2023 Q4	$25.1M	Buy	106,040 +169	+0.2%	+$33.2K	1.5%	29
2023 Q3	$20.7M	Sell	105,871 -1,187	-1%	-$244K	1.38%	28
2023 Q2	$22.5M	Buy	107,058 +2,253	+2%	+$448K	1.45%	30
2023 Q1	$21.2M	Buy	+104,805	New	+$23.8M	1.44%	30

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's CRL Position: Q2 2026 in Review

Woodley Farra Manion Portfolio Management held its Charles River Laboratories (CRL) position steady in Q2 2026 at 1,269 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #112.

Woodley Farra Manion Portfolio Management first reported a position in CRL in Q1 2023 and has held it in 13 quarters since. The position peaked at $65.9M in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Woodley Farra Manion Portfolio Management held 1,269 shares of Charles River Laboratories worth $288K as of Q2 2026.
Woodley Farra Manion Portfolio Management left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up 0.01% of Woodley Farra Manion Portfolio Management's portfolio in Q2 2026, its #112 holding.
Woodley Farra Manion Portfolio Management first reported a position in Charles River Laboratories in Q1 2023 and has held it in 13 quarters since.
Woodley Farra Manion Portfolio Management's Charles River Laboratories position peaked at $65.9M in Q1 2024.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q2 2026, filed 10 Aug 2026.